• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Bristol-Myers Squibb

Bristol-Myers Squibb

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  5. Research
  1. Allied Minds and Bristol-Myers Squibb Form New Enterprise to Advance Discoveries of Biopharmaceutical Innovations at Leading U.S. Academic Research Institutions

    Allied Minds and Bristol-Myers Squibb Form New Enterprise to Advance Discoveries of Biopharmaceutical Innovations at Leading U.S. Academic Research Institutions

  2. Allied Minds Forms University Research Venture with Bristol -Myers

    Allied Minds Forms University Research Venture with Bristol - Myers

  3. Research and Markets: Global PCOS (Stein-Leventhal Syndrome) Drugs Market 2014-2018

    Research and Markets: Global PCOS (Stein-Leventhal Syndrome) Drugs Market 2014-2018

  4. Avion Pharmaceuticals, LLC, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products

    Avion Pharmaceuticals, LLC, signs Captisol® License Agreement with Ligand Pharmaceuticals to develop four new products

  5. Cortendo Appoints Matthew Pauls as Chief Executive Officer

    Cortendo Appoints Matthew Pauls as Chief Executive Officer

  6. Finding the True Champion Dividend-Growth Funds

    There is more competition among dividend-growth funds, making it harder to truly stand out.

  7. Gilead Sciences Carving Out a Wider Moat

    StockInvestor editor Matt Coffina and senior biotech analyst Karen Andersen discuss Gilead's growing competitive advantages.

  8. Our Outlook for the Credit Markets

    Widening investment-grade credit spreads and rising interest rates lead to losses.

1234
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.